The global injectable drug delivery technologies market size is estimated to be USD 595.8 billion in 2021 and is expected to witness a CAGR of 12.45% during the forecast period. Acceleration in the global demand for self- injection devices is a key driver for the growth of the global injectable drug delivery technologies market. Additionally, the surge in the number of patients suffering from chronic diseases and high rate of technological innovation in the market in the injectable drug delivery technologies market are some of the other drivers propelling the market growth. Nevertheless, the rising incidence of needle stick injuries and preference for alternative modes of drug delivery is expected to restrain the global market growth.
Global Injectable Drug Delivery Technologies Market Size (USD Billion), 2021-2029
Source: Erevna Healthcare
By Drug Delivery
Based on drug delivery, the market is segmented into formulations and devices. In 2021, the formulations segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is attributed to increasing investment R&D and the usage of colloidal dispersions in the drug delivery systems is significantly rising worldwide. Devices segment projected to grow at a profitable CAGR during the forecast period. This is attributed to the increasing use of these devices as they help in the management and control of several disorders at the initial level.
By Therapeutic Use
Based on therapeutic use, the market is categorized into hormonal disorders, autoimmune disorders, oncology, and others. In 2021, the oncology segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the use of chemotherapy for the treatment of cancer use injectable drug delivery devices to a great range worldwide. The hormonal disorders segment is anticipated to grow at a profitable CAGR during the forecast period, due to the launch of new products and shift towards the treatment of growth hormone deficiency are the key factors driving the market worldwide.
By End User
Based on end user, the market is categorized into homecare settings, hospital, and others. In 2021, the homecare settings segment accounted for the substantial revenue share with lucrative CAGR during the forecast period. This is due to the increase in the number of patients who are able to administer drugs at home without any medical help worldwide. The hospital segment is anticipated to grow at a profitable CAGR during the forecast period, due to the increasing number of diabetic patients globally.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the favorable repayment scenarios, presence of major players in the region, accessibility of technologically advanced products in the region. Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the less stringent regulations, growing government and corporate investment in the healthcare sector, large population in various countries in the region, and availability of skilled labour forces at economic costs, are the major factors in this region.
Competitor Insights
Some of the key players in the injectable drug delivery technologies market are Pfizer, Inc. (U.S.); Baxter International, Inc. (U.S.); Schott AG (Germany); Becton, Dickinson and Company (U.S.); Eli Lilly and Company (U.S.); Alkermes PLC (Ireland); Terumo Corporation (Japan); Elcam Medical (Israel); Unilife Corporation (U.S.); and Ypsomed (Switzerland). The leading players operating in the injectable drug delivery technologies industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.
This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2021 to 2029. The injectable drug delivery technologies market report is categorized into the following segments and subsegments:
Injectable Drug Delivery Technologies Market, By Drug Delivery (Revenue, USD Billion, 2021 – 2029)
- By Formulations
- Conventional drug delivery
- Novel drug delivery
- Others
- By Devices
- Self-Injection devices
- Conventional devices
Injectable Drug Delivery Technologies Market, By Therapeutic Use (Revenue, USD Billion, 2021 – 2029)
- Hormonal disorders
- Autoimmune disorders
- Oncology
- Others
Injectable Drug Delivery Technologies Market, By End User (Revenue, USD Billion, 2021 – 2029)
- Homecare Settings
- Hospital
- Others
Injectable Drug Delivery Technologies Market, By Region (Revenue, USD Billion, 2021 – 2029)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Scope of Injectable Drug Delivery Technologies Market Report:
Key Parameters | Details |
---|---|
Base Year |
|
Forecast Period |
|
Study Coverage |
|
Qualitative Analysis |
|
Regional Market Scope |
|
Company Profiles |
|
15% Free Customization Available |
|
Table of Contents: Injectable Drug Delivery Technologies Market 2021-2029
- Research Methodology
- Study Objectives
- Study Scope
- Research Assumptions
- Research Framework
- Research Models
- Bottom-up Approach
- Top-down Approach
- Data Triangulation
- Data Procurement
- Internal Database
- Secondary Research
- Purchased Database
- Primary Research
- Data Analysis
- Data Validation
- Market Size Estimation
- Market Forecast Model
- Quality Assessment
- Research Models
- Introduction: Injectable Drug Delivery Technologies
- Executive Summary
- Global Market Scenario
- Segment Market Scenario
- Geographic Market Scenario
- COVID-19 Impact
- Competitive Landscape
- Market Dynamics
- Market Drivers
- Driver 1
- Driver 2
- Driver 3
- Driver 4
- Driver 5
- Market Restraint
- Restraint 1
- Restraint 2
- Restraint 3
- Restraint 4
- Market Opportunities
- Opportunity 1
- Opportunity 2
- Opportunity 3
- Opportunity 4
- Market Trends
- Trend 1
- Trend 2
- Trend 3
- Trend 4
- Market Challenges
- Challenge 1
- Challenge 2
- Challenge 3
- Challenge 4
- Market Drivers
- Market Environment Analysis
- Porter’s 5 Forces Analysis
- PESTEL Analysis
- Value Chain Analysis
- SWOT Analysis
- Benchmark
- COVID-19 Impact Analysis: Injectable Drug Delivery Technologies Market
- COVID-19: Overview
- COVID-19 Impact on the Global Market
- COVID-19 Impact on the Regional Markets
- Market Analysis by Drug Delivery
- Formulations
- Formulations Market Forecast, 2021-2029 (USD Million)
- Devices
- Devices Market Forecast, 2021-2029 (USD Million)
- Formulations
- Market Analysis by Therapeutic Use
- Hormonal Disorders
- Hormonal Disorders Market Forecast, 2021-2029 (USD Million)
- Autoimmune Disorders
- Autoimmune Disorders Market Forecast, 2021-2029 (USD Million)
- Oncology
- Oncology Market Forecast, 2021-2029 (USD Million)
- Hormonal Disorders
- Market Analysis by End User
- Homecare Settings
- Homecare Settings Market Forecast, 2021-2029 (USD Million)
- Hospital
- Hospital Market Forecast, 2021-2029 (USD Million)
- Others
- Others Market Forecast, 2021-2029 (USD Million)
- Homecare Settings
- Regional Market Analysis
- Regional Market Trends
- Regional Market: Comparative Analysis
- North America Injectable Drug Delivery Technologies Market
- North America Injectable Drug Delivery Technologies Market
- North America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- S. Injectable Drug Delivery Technologies Market
- S. Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Canada Injectable Drug Delivery Technologies Market
- Canada Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Canada Market Size and Forecast, 2021-2029 (USD Million)
- S. Market Size and Forecast, 2021-2029 (USD Million)
- North America Market Size and Forecast, 2021-2029 (USD Million)
- North America Injectable Drug Delivery Technologies Market
- Europe Injectable Drug Delivery Technologies Market
- Europe Injectable Drug Delivery Technologies Market
- Europe Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Germany Injectable Drug Delivery Technologies Market
- Germany Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- UK Injectable Drug Delivery Technologies Market
- UK Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- France Injectable Drug Delivery Technologies Market
- France Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Spain Injectable Drug Delivery Technologies Market
- Spain Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Italy Injectable Drug Delivery Technologies Market
- Italy Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Rest of Europe Injectable Drug Delivery Technologies Market
- Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
- Italy Market Size and Forecast, 2021-2029 (USD Million)
- Spain Market Size and Forecast, 2021-2029 (USD Million)
- France Market Size and Forecast, 2021-2029 (USD Million)
- UK Market Size and Forecast, 2021-2029 (USD Million)
- Germany Market Size and Forecast, 2021-2029 (USD Million)
- Europe Market Size and Forecast, 2021-2029 (USD Million)
- Europe Injectable Drug Delivery Technologies Market
- Asia Pacific Injectable Drug Delivery Technologies Market
- Asia Pacific Injectable Drug Delivery Technologies Market
- Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Japan Injectable Drug Delivery Technologies Market
- Japan Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- China Injectable Drug Delivery Technologies Market
- China Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- India Injectable Drug Delivery Technologies Market
- India Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- South Korea Injectable Drug Delivery Technologies Market
- South Korea Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Australia Injectable Drug Delivery Technologies Market
- Australia Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Rest of Asia Pacific Injectable Drug Delivery Technologies Market
- Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Australia Market Size and Forecast, 2021-2029 (USD Million)
- South Korea Market Size and Forecast, 2021-2029 (USD Million)
- India Market Size and Forecast, 2021-2029 (USD Million)
- China Market Size and Forecast, 2021-2029 (USD Million)
- Japan Market Size and Forecast, 2021-2029 (USD Million)
- Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
- Asia Pacific Injectable Drug Delivery Technologies Market
- Latin America Injectable Drug Delivery Technologies Market
- Latin America Injectable Drug Delivery Technologies Market
- Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Brazil Injectable Drug Delivery Technologies Market
- Brazil Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Mexico Injectable Drug Delivery Technologies Market
- Mexico Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Argentina Injectable Drug Delivery Technologies Market
- Argentina Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Rest of Latin America Injectable Drug Delivery Technologies Market
- Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Argentina Market Size and Forecast, 2021-2029 (USD Million)
- Mexico Market Size and Forecast, 2021-2029 (USD Million)
- Brazil Market Size and Forecast, 2021-2029 (USD Million)
- Latin America Market Size and Forecast, 2021-2029 (USD Million)
- Latin America Injectable Drug Delivery Technologies Market
- MEA Injectable Drug Delivery Technologies Market
- MEA Injectable Drug Delivery Technologies Market
- MEA Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- GCC Injectable Drug Delivery Technologies Market
- GCC Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- South Africa Injectable Drug Delivery Technologies Market
- South Africa Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Rest of MEA Injectable Drug Delivery Technologies Market
- Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
- Market Size and Forecast by Drug Delivery, 2021-2029 (USD Million)
- Market Size and Forecast by Therapeutic Use, 2021-2029 (USD Million)
- Market Size and Forecast byEnd User, 2021-2029 (USD Million)
- Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
- South Africa Market Size and Forecast, 2021-2029 (USD Million)
- GCC Market Size and Forecast, 2021-2029 (USD Million)
- MEA Market Size and Forecast, 2021-2029 (USD Million)
- MEA Injectable Drug Delivery Technologies Market
- Competitor Analysis
- Market Share Analysis, 2021 & 2029
- Competitive Mapping
- Key Players Market Place Analysis
- Major Recent Developments
- Company Profiles
- Pfizer, Inc. (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Baxter International, Inc. (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Schott AG (Germany)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Becton, Dickinson and Company (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Eli Lilly and Company (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Alkermes PLC (Ireland)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Terumo Corporation (Japan)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Elcam Medical (Israel)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Unilife Corporation (U.S.)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Ypsomed (Switzerland)
- Company Snapshot
- Company Overview
- Financials
- Therapeutic Use Benchmarking
- Recent Developments
- Company 11
- Company Snapshot
- Company Overview
- Financials
- Drug Delivery Benchmarking
- Recent Developments
- Company 12
- Company Snapshot
- Company Overview
- Financials
- Drug Delivery Benchmarking
- Recent Developments
- Company 13
- Company Snapshot
- Company Overview
- Financials
- Drug Delivery Benchmarking
- Recent Developments
- Company 14
- Company Snapshot
- Company Overview
- Financials
- Drug Delivery Benchmarking
- Recent Developments
- Company 15
- Company Snapshot
- Company Overview
- Financials
- Drug Delivery Benchmarking
- Recent Developments
- Others Prominent Players
- Pfizer, Inc. (U.S.)
Conclusion & Recommendations